United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - metamizole sodium (unii: vsu62z74on) (metamizole - unii:934t64rmnj) - metamizole 495 g in 500 g

United States - English - NLM (National Library of Medicine)

american pharmaceutical ingredients llc - metamizole sodium (unii: vsu62z74on) (metamizole sodium - unii:vsu62z74on) -

United States - English - NLM (National Library of Medicine)

professional group of pharmacists new york llc - metamizole sodium (unii: vsu62z74on) (metamizole - unii:934t64rmnj) -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aripiprazole, quantity: 2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; hyprolose; lactose monohydrate; iron oxide yellow; microcrystalline cellulose; maize starch; indigo carmine aluminium lake - aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aripiprazole, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; indigo carmine aluminium lake; maize starch; colloidal anhydrous silica; hyprolose; magnesium stearate - aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aripiprazole, quantity: 5 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; hyprolose; indigo carmine aluminium lake; microcrystalline cellulose; maize starch; magnesium stearate - aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aripiprazole, quantity: 15 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; hyprolose; magnesium stearate; maize starch; microcrystalline cellulose - aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aripiprazole, quantity: 30 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; maize starch; magnesium stearate; hyprolose; colloidal anhydrous silica - aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aripiprazole, quantity: 2 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; hyprolose; indigo carmine aluminium lake; maize starch; colloidal anhydrous silica; iron oxide yellow; lactose monohydrate; magnesium stearate - aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aripiprazole, quantity: 10 mg - tablet, uncoated - excipient ingredients: magnesium stearate; hyprolose; microcrystalline cellulose; lactose monohydrate; maize starch; colloidal anhydrous silica - aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.